The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity

Overview of attention for article published in Frontiers in immunology, November 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 4 news outlets

twitter: 86 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 56 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 94 X posts from 86 X users, with an upper bound of 249,912 followers.

https://t.co/1u81DXsmXp

17 Mar 2022

Reply Repost Favourite

RT @SanchoLab: Happy to share our @FrontImmunol with our grain of sand to improve innate #immunity and #vaccine efficacy against #COVID-19.…

24 Feb 2022

Reply Repost Favourite

This work was also in the inception of our recently published work in which we apply MV130 pretreatment to protect against #SARS-CoV-2 and improve the immunogenicity of #COVID-19 vaccines (11/12). The new work provides one of the potential mechanisms! http

07 Jan 2022

Reply Repost Favourite

RT @SanchoLab: Happy to share our @FrontImmunol with our grain of sand to improve innate #immunity and #vaccine efficacy against #COVID-19.…

16 Dec 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 90 additional X posts.